In this interview, Bruce Levy, MD describes the loss of inflammatory ‘breaking signals’ in the lung of patients with asthma. Dr. Levy highlights how this defective resolution phenotype negatively impacts both adaptive and innate immune responses in individuals with asthma, leaving them more vulnerable to infection.
Bruce Levy, MD is the Chief of the Division of Pulmonary and Critical Care Medicine at Brigham and Women’s Hospital, MA and Parker B. Francis Professor at Harvard Medical School
From the 16th International Conference on Bioactive Lipids in Cancer, Inflammation and Related Diseases, October 2019 in St Petersburg, Florida
